Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Photochem Photobiol B ; 250: 112816, 2024 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-38029664

RESUMEN

Although photobiomodulation (PBM) and gamma visual stimulatqion (GVS) have been overwhelmingly explored in the recent time as a possible light stimulation (LS) means of Alzheimer's disease (AD) therapy, their effects have not been assessed at once. In our research, the AD mouse model was stimulated using light with various parameters [continuous wave (PBM) or 40 Hz pulsed visible LED (GVS) or 40 Hz pulsed 808 nm LED (PBM and GVS treatment)]]. The brain slices collected from the LS treated AD model mice were evaluated using (i) fluorescence microscopy to image thioflavine-S labeled amy-loid-ß (Aß) plaques (the main hallmark of AD), or (ii) two-photon excited fluorescence (TPEF) imaging of unlabeled Aß plaques, showing that the amount of Aß plaques was reduced after LS treatment. The imaging results correlated well with the results of Morris water maze (MWM) test, which demonstrated that the spatial learning and memory abilities of LS treated mice were noticeably higher than those of untreated mice. The LS effect was also assessed by in vivo nonlinear optical imaging, revealing that the cerebral amyloid angiopathy decreased spe-cifically as a result of 40 Hz pulsed 808 nm irradiation, on the contrary, the angiopathy reversed after visible 40 Hz pulsed light treatment. The obtained results provide useful reference for further optimization of the LS (PBM or GVS) parameters to achieve efficient phototherapy of AD.


Asunto(s)
Enfermedad de Alzheimer , Terapia por Luz de Baja Intensidad , Ratones , Animales , Estimulación Luminosa , Terapia por Luz de Baja Intensidad/métodos , Encéfalo/metabolismo , Placa Amiloide , Péptidos beta-Amiloides , Modelos Animales de Enfermedad , Ratones Transgénicos
2.
J Mater Chem B ; 3(35): 7068-7078, 2015 Sep 21.
Artículo en Inglés | MEDLINE | ID: mdl-32262709

RESUMEN

The alarming rise in antibiotic-resistant pathogenic bacteria demands a prudent approach in the generation of therapeutic antibacterials. The present study illustrates the development of a potent amphiphilic bactericidal material tailored to leverage interactions with metal-reactive groups (MRGs) present in the bacterial cell surface envelope. Complexation of Zn(ii) with a neutral pyridine-based synthetic amphiphile (C1) generated the cationic C1-Zn, which exhibited manyfold higher membrane-directed bactericidal activity compared to the neutral C1, or the cationic amphiphile bearing two pyridinium head groups (C2). The relevance of MRGs in C1-Zn-bacteria interactions was validated by amphiphile-bacteria binding studies and metal protection assays performed with Mg(ii). C1-Zn retained its bactericidal activity even in simulated gastric fluid (SGF) and the enhanced membrane-directed bactericidal activity of C1-Zn could be garnered in adjuvant applications to increase the efficacy of the therapeutic antibiotic erythromycin. Given the relevance of Zn(ii) in S. aureus biofilm formation, the antibiofilm potential of the amphiphile C1 realized through Zn(ii) complexation could be demonstrated. The lack of resistance in target bacteria coupled with a favorable therapeutic index (IC50/MIC) and non-toxic nature hold significant implications for C1-Zn as a potential antibacterial therapeutic material.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA